MSc. Thesis Defense: Esra Sinoplu
  • FENS
  • MSc. Thesis Defense: Esra Sinoplu

You are here

DEVELOPMENT OF SPION-BASED THERANOSTIC NANOCARRIERS FOR SMALL RNA DELIVERY AND CANCER GENE THERAPY

 

 

ESRA SINOPLU
Molecular Biology, Genetics and Bioengineering, MSc. Thesis, 2016

 

Thesis Jury

Assoc. Prof. Devrim Gozuacik (Thesis Advisor), Assoc. Prof. Havva Funda Yagci Acar,

Prof. Dr. Ali Koşar

 

 

Date & Time: August4th, 2016 –  10:30AM

 

Place: FENS L067

Keywords : Nanomedicine, nanoparticle-based gene therapy, microRNA, cancer

 

Abstract

 

Nanoparticles can be used for medical purposes, including diagnosis, therapy and follow-up of diseases. In recent years, small RNAs including microRNAs have emerged as novel diagnostic and therapeutic tools in the field of cancer research. Combination of nanoparticles with small RNAs has the potential to open new avenues for targeted gene therapy of diseases including, cancer.

In this thesis, multifunctional and biocompatible superparamagnetic iron oxide nanoparticles (SPIONs) were created and tested for gene therapy purposes. Nanoparticles were covered with polymers, coated with RNA binding (RB) proteins and antibodies in order to target and kill tumor cells. MicroRNA-based patented drugs were utilized as payload. Components that were used to create multifunctional and biocompatible SPIONs were strongly binding RNAs, increasing their stability, specifically recognizing HER2+ breast cancer cells, and effectively modulating autophagy. Moreover, to facilitate tracing, fluorescent probes were added to nanoparticles. Magnetic manipulation tests were also performed.

 

These novel theranostic, multifunctional and cancer-targeting nanoparticles may potentially be used alone or in combination with chemotherapy drugs for cancer treatment purposes. Exploitation of these particles for the diagnosis and hyperthermia treatment of primary and metastatic tumors is also possible.